Skip to main content
SpringerLink
Log in

Percutaneous Management of Peripheral Arterial Disease

  • Chapter
  • First Online:
Book cover Device Therapy in Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 865 Accesses

Abstract

Peripheral arterial disease (PAD) affects tens of millions of patients, with the prevalence of the disease directly proportional to age. PAD is a marker for high cardiovascular risk, and many PAD patients have impaired left ventricular function and heart failure. Symptomatic PAD can have effective and durable outcomes with either an endovascular or a surgical intervention. This chapter reviews the clinical approach to PAD as well as the devices available to treat it.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317–24.

    Article  CAS  PubMed  Google Scholar 

  2. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94(11):3026–49.

    CAS  PubMed  Google Scholar 

  3. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984;199(2):223–33.

    Article  CAS  PubMed  Google Scholar 

  4. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation 1964;30:654–70.

    CAS  PubMed  Google Scholar 

  5. Brewster D. Direct reconstruction for aortoiliac occlusive disease. In: Rutherford R, ed. Vascular Surgery. Philadelphia, PA: WB Saunders; 1995:766–94.

    Google Scholar 

  6. Tetteroo E, Haaring C, van der Graaf Y, van Schaik JP, van Engelen AD, Mali WP. Intraarterial pressure gradients after randomized angioplasty or stenting of iliac artery lesions. Dutch Iliac Stent Trial Study Group. Cardiovasc Intervent Radiol 1996;19(6):411–7.

    Article  CAS  PubMed  Google Scholar 

  7. Martin EC, Katzen BT, Benenati JF, et al. Multicenter trial of the Wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995;6(6):843–9.

    Article  CAS  PubMed  Google Scholar 

  8. Vorwerk D, Gunther RW, Schurmann K, Wendt G. Aortic and iliac stenoses: follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology 1996;198(1):45–8.

    CAS  PubMed  Google Scholar 

  9. Murphy TP, Webb MS, Lambiase RE, et al. Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of Wallstents: three-year experience. J Vasc Interv Radiol 1996;7(1):21–7.

    Article  CAS  PubMed  Google Scholar 

  10. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2–4-year follow-up. Radiology 1995;197(1):167–74.

    CAS  PubMed  Google Scholar 

  11. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(1 Pt 2):S1–296.

    CAS  PubMed  Google Scholar 

  12. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5–67.

    Article  PubMed  Google Scholar 

  13. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg (Torino) 2004;45(3):193–201.

    CAS  Google Scholar 

  14. Lee ES, Santilli SM, Olson MM, Kuskowski MA, Lee JT. Wound infection after infrainguinal bypass operations: multivariate analysis of putative risk factors. Surg Infect (Larchmt) 2000;1(4):257–63.

    Article  CAS  Google Scholar 

  15. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366(9501):1925–34.

    Article  CAS  PubMed  Google Scholar 

  16. Ansel GM, Silver MJ, Botti CF, Jr., et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial. Catheter Cardiovasc Interv 2006;67(2):288–97.

    Article  PubMed  Google Scholar 

  17. Waksman R, Laird JR, Jurkovitz CT, et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 2001;12(8):915–21.

    Article  CAS  PubMed  Google Scholar 

  18. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13(6):701–10.

    Article  PubMed  Google Scholar 

  19. Greenberg D, Rosenfield K, Garcia LA, et al. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). J Vasc Interv Radiol 2004;15(10):1065–9.

    PubMed  Google Scholar 

  20. Jeans WD, Armstrong S, Cole SE, Horrocks M, Baird RN. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990;177(2):559–64.

    CAS  PubMed  Google Scholar 

  21. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83(2 Suppl):I70–80.

    CAS  PubMed  Google Scholar 

  22. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183(3):767–71.

    CAS  PubMed  Google Scholar 

  23. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1–3-year follow-up. Radiology 1994;191(3):727–33.

    CAS  PubMed  Google Scholar 

  24. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> or = 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology 1995;195(1):158–62.

    CAS  PubMed  Google Scholar 

  25. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995;274(2):165–71.

    Article  CAS  PubMed  Google Scholar 

  26. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70(4):619–23.

    CAS  PubMed  Google Scholar 

  27. Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology 1985;156(2):325–8.

    CAS  PubMed  Google Scholar 

  28. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC. Femoropopliteal stent placement: long-term results. Radiology 1992;184(3):833–9.

    CAS  PubMed  Google Scholar 

  29. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting – the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005;12(6):676–84.

    Article  PubMed  Google Scholar 

  30. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45(2):312–5.

    Article  PubMed  Google Scholar 

  31. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354(18):1879–88.

    Article  CAS  PubMed  Google Scholar 

  32. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106(12):1505–9.

    Article  CAS  PubMed  Google Scholar 

  33. Zilberman M, Eberhart RC. Drug-eluting bioresorbable stents for various applications. Annu Rev Biomed Eng 2006;8:153–80.

    Article  CAS  PubMed  Google Scholar 

  34. Biamino JLG. Results of the cryovascular peripheral balloon catheter safety registry. In: Transcatheter Cardiovascular Therapeutics. Washington, DC; 2003.

    Google Scholar 

  35. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006;48(8):1573–8.

    Article  PubMed  Google Scholar 

  36. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther 2006;13(5):592–602.

    Article  PubMed  Google Scholar 

  37. Fischer M, Schwabe C, Schulte KL. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006;13(3):281–90.

    Article  PubMed  Google Scholar 

  38. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 2001;8(3):315–20.

    Article  CAS  PubMed  Google Scholar 

  39. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral–popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45(1):10–6; discussion 6.

    Article  PubMed  Google Scholar 

  40. Pomposelli FB, Jr., Marcaccio EJ, Gibbons GW, et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995;21(3):375–84.

    Article  PubMed  Google Scholar 

  41. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001;104(17):2057–62.

    Article  CAS  PubMed  Google Scholar 

  42. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44(12):2307–14.

    Article  PubMed  Google Scholar 

  43. Laird JR, Zeller T, Gray BH, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006;13(1):1–11.

    Article  PubMed  Google Scholar 

  44. Kandzari DE, Kiesz RS, Allie D, et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther 2006;13(1): 12–22.

    Article  PubMed  Google Scholar 

  45. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002;77(4):309–16.

    Article  PubMed  Google Scholar 

  46. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE, Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 1994;19(2):250–7; discussion 7–8.

    CAS  PubMed  Google Scholar 

  47. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342(14):1007–14.

    Article  PubMed  Google Scholar 

  48. Dorros G, Jaff M, Mathiak L, He T. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 2002;55(2):182–8.

    Article  PubMed  Google Scholar 

  49. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344(6):410–7.

    Article  CAS  PubMed  Google Scholar 

  50. Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142(2):314–23.

    Article  CAS  PubMed  Google Scholar 

  51. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000;139(1 Pt 1):64–71.

    Article  CAS  PubMed  Google Scholar 

  52. White CJ, Ramee SR, Collins TJ, Jenkins JS, Escobar A, Shaw D. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 1997;30(6):1445–50.

    Article  CAS  PubMed  Google Scholar 

  53. Rocha-Singh KJ, Mishkel GJ, Katholi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv 1999;47(2): 167–72.

    Article  CAS  PubMed  Google Scholar 

  54. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg 1999;29(4):617–24.

    Article  CAS  PubMed  Google Scholar 

  55. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152(1):59–66.

    Article  PubMed  Google Scholar 

  56. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325(7):445–53.

    Google Scholar 

  57. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421–8.

    Google Scholar 

  58. European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351(9113):1379–87.

    Google Scholar 

  59. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006;44(2):258–68.

    Article  PubMed  Google Scholar 

  60. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351(15):1493–501.

    Article  CAS  PubMed  Google Scholar 

  61. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357(9270):1729–37.

    Google Scholar 

  62. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355(16):1660–71.

    Article  CAS  PubMed  Google Scholar 

  63. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368(9543):1239–47.

    Article  CAS  PubMed  Google Scholar 

  64. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007;69(3):341–8.

    Article  PubMed  Google Scholar 

  65. Wholey MH, Al-Mubarek N. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60(2):259–66.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Mobeen A. Sheikh MD

  2. Cardiac Catheterization Laboratory, St. Elizabeth Medical Center, Boston, MA, USA

    Lawrence A. Garcia MD (Director)

Authors
  1. Mobeen A. Sheikh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence A. Garcia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Pilgrim Road 185, Boston, 02215, U.S.A.

    William H. Maisel

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Sheikh, M.A., Garcia, L.A. (2010). Percutaneous Management of Peripheral Arterial Disease. In: Maisel, W. (eds) Device Therapy in Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-424-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-424-7_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-994-9

  • Online ISBN: 978-1-59745-424-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation